Sequence Similarity Clusters for the Entities in PDB 6IAP

Entity #1 | Chains: A
Natural cytotoxicity triggering receptor 1 protein, length: 182 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 50157
95 % 2 2 42075 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 1.6
PDBFlex
90 % 2 2 31971
70 % 2 2 35507
50 % 2 2 30827
40 % 22 32 1422
30 % 27 39 1215
Entity #2 | Chains: D
Fab NKp46-4 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 71586
95 % 1 1 44112
90 % 459 784 2
70 % 1509 2399 2
50 % 1888 3045 2
40 % 1888 3045 2
30 % 3839 6183 1
Entity #3 | Chains: E
Fab NKp46-4 heavy chain protein, length: 217 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 71585
95 % 1 1 59017
90 % 1 1 55645
70 % 1825 2943 1
50 % 1926 3094 1
40 % 1926 3094 1
30 % 3840 6183 1
Entity #4 | Chains: H
Fab NKp46-1 heavy chain protein, length: 220 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 1 71588
95 % 2 2 42448 Flexibility: Low
Max RMSD: 1.1, Avg RMSD: 1.1
PDBFlex
90 % 2 2 40497
70 % 1826 2943 1
50 % 1927 3094 1
40 % 1927 3094 1
30 % 3841 6183 1
Entity #5 | Chains: L
Fab NKp46-1 light chain protein, length: 211 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 2 57729
95 % 9 10 5390 Flexibility: Low
Max RMSD: 1.9, Avg RMSD: 0.9
PDBFlex
90 % 460 784 2
70 % 1510 2399 2
50 % 1889 3045 2
40 % 1889 3045 2
30 % 3842 6183 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 4P48 1 A Antibody scFv 180 9031
21 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
22 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
23 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
24 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
25 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
26 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
27 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
28 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
29 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
30 6MEE 2 B, D antibody HEPC74 Light Chain 9606
31 6BJZ 1 H 5c8 Fab Heavy chain 9606
32 6BJZ 2 L 5c8 Fab Light chain 9606
33 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
34 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
35 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
36 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
37 4XCF 1 L 4E10 Fab light chain 9606
38 4XCF 2 H 4E10 Fab heavy chain 9606
39 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
40 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
41 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
42 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
43 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
44 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
45 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
46 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
47 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
48 5X08 1 H Fab 4E10 Heavy chain 9606
49 5X08 2 L Fab 4E10 Light chain 9606
50 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
51 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
52 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
53 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
54 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
55 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
56 6MEG 1 H antibody HEPC46 Heavy Chain 9606
57 6MEG 2 L antibody HEPC46 Light Chain 9606
58 4XAW 1 L 4E10 Fab light chain 9606
59 4XAW 2 H 4E10 Fab heavy chain 9606
60 4P49 1 A Antibody scFv B8 9031
61 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
62 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
63 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
64 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
65 5UCB 1 H Fab Heavy Chain 9606
66 5UCB 2 L Fab Light Chain 9606
67 2VXV 1 H HUMAN IGG ABT-325 9606
68 2VXV 2 L HUMAN IGG ABT-325 9606
69 6QF9 1 A, B scFv 9606
70 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
71 4GXV 1 H, I Antibody 1F1, heavy chain 9606
72 4GXV 2 L, M Antibody 1F1, light chain 9606
73 2VXT 1 H MURINE IGG 125-2H 10090
74 2VXT 3 L MURINE IGG 125-2H 10090
75 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
76 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
77 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
78 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
79 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
80 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
81 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
82 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
83 5W24 1 L 5C4 Fab Light Chain 10090
84 5W24 2 H 5C4 Fab Heavy Chain 10090
85 4HPY 1 H CH59 Fab heavy chain 9606
86 4HPY 2 L CH59 Fab light chain 9606
87 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
88 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
89 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
90 4JG1 1 L Fab light chain 9606
91 4JG1 2 H Fab heavy chain 9606
92 6E65 1 L TB31F Fab light chain 9606
93 6E65 2 H TB31F Fab heavy chain 9606
94 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
95 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
96 5VF2 1 A scFv 2D10 10090
97 5I8C 1 A VRC34.01 Fab heavy chain 9606
98 5I8C 2 B VRC34.01 Fab light chain 9606
99 4O5L 1 L Fab F045-092 light chain 9606
100 4O5L 2 H Fab F045-092 heavy chain 9606
101 5MYX 1 A, C Fab c#24 light chain 10090
102 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
103 3IFL 1 L 12A11 FAB antibody light chain 10090
104 3IFL 2 H 12A11 FAB antibody heavy chain 10090
105 5WK2 1 L M116 LIGHT CHAIN 9606
106 5WK2 2 H M116 HEAVY CHAIN FD 9606
107 3PP4 1 H GA101 Fab heavy chain 10090
108 3PP4 2 L GA101 Fab light chain 10090
109 3KDM 1 A, L Immunoglobulin light chain 9606
110 3KDM 2 B, H Immunoglobulin heavy chain 9606
111 5NIV 1 A Light chain of 5D3 Fab 10090
112 5NIV 2 B Heavy chain of 5D3 Fab 10090
113 5N4J 1 L LIGHT CHAIN 9606
114 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
115 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
116 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
117 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
118 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
119 5X4G 1 A 6H8 Fab heavy chain 10090
120 5X4G 2 B 6H8 Fab light chain 10090
121 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
122 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
123 4PTU 1 A Antibody pn132p2C05, light chain 9606
124 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
125 4TPR 1 L If kappa light chain 10090
126 4TPR 2 H Fab heavy chain 10090
127 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
128 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
129 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
130 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
131 3IFN 1 H 12A11 FAB antibody heavy chain 10090
132 3IFN 2 L 12A11 FAB antibody light chain 10090
133 5U3P 1 H DH511.4 Fab Heavy Chain 9606
134 5U3P 2 L DH511.4 Fab Light Chain 9606
135 6BLA 1 H AMM01 Fab Heavy chain 9606
136 6BLA 2 L AMM01 Fab Light chain 9606
137 4TOY 1 H 35O22 Fab Heavy chain 9606
138 4TOY 2 L 35O22 Fab Light chain 9606
139 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
140 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
141 3NPS 2 B S4 FAB HEAVY CHAIN 9606
142 3NPS 3 C S4 FAB LIGHT CHAIN 9606
143 5I4F 1 A scFv 2D10 10090
144 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
145 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
146 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
147 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
148 5WN9 1 H scFv 2D10 9606
149 4XC3 1 L 4E10 Fab light chain 9606
150 4XC3 2 H 4E10 Fab heavy chain 9606
151 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
152 4M5Y 1 H, I Fab 5J8 heavy chain 9606
153 4M5Y 2 L, M Fab 5J8 light chain 9606
154 4TQE 1 L If kappa light chain 10090
155 4TQE 2 H Fab heavy chain 10090
156 5YY4 1 A scFv 4B08 10090
157 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
158 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
159 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
160 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
161 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
162 5VSI 2 L CH1/Ckappa Fab light chain 9606
163 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
164 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
165 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
166 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
167 5JXA 1 H VRC03 Heavy chain 9606
168 5JXA 2 L VRC03 Light chain 9606
169 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
170 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
171 6QCU 1 L Light chain 9606
172 6QCU 2 H Heavy chain 9606
173 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
174 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
175 3NTC 1 L Fab light chain 10090
176 3NTC 2 H Fab heavy chain 10090
177 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
178 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
179 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
180 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
181 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
182 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
183 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
184 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
185 6BE3 1 H Fab (F598) Heavy Chain 9606
186 6BE3 2 L Fab (F598) Light Chain 9606
187 4NWU 1 H APE1551 Ab Fab heavy chain 9606
188 4NWU 2 L APE1551 Ab Fab light chain 9606
189 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
190 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
191 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
192 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
193 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
194 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
195 5EWI 1 H VRC38.01 Heavy Chain 9606
196 5EWI 2 L VRC38.01 Light Chain 9606
197 5E2W 1 L AT8 LIGHT CHAIN 10090
198 5E2W 2 H AT8 HEAVY CHAIN 10090
199 5MYK 1 A Fab c#17 light chain 10090
200 5MYK 2 B Fab c#17 heavy chain 10090
201 4NZR 1 H PGT135 heavy chain Fab 9606
202 4NZR 2 L PGT135 light chain Fab 9606
203 5MYO 1 A, C Fab c#6 light chain 10090
204 5MYO 2 B, D Fab c#6 heavy chain 10090
205 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
206 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
207 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
208 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
209 5UEL 1 H 354NC102 Fab Heavy Chain 9606
210 5UEL 2 L 354NC102 Fab Light Chain 9606
211 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
212 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
213 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
214 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
215 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
216 5E2V 1 L AT8 LIGHT CHAIN 10090
217 5E2V 2 H AT8 HEAVY CHAIN 10090
218 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
219 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
220 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
221 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
222 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
223 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
224 5JUE 1 L light chain of UIC2 Fab 10090
225 5JUE 2 H heavy chain of UIC2 Fab 10090
226 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
227 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
228 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
229 5JR1 1 H 10E8 heavy chain 9606
230 5JR1 2 L 10E8 mature light chain 9606
231 6CA7 1 L PCT64_13C light chain 9606
232 6CA7 2 H PCT64_13C heavy chain 9606
233 5VF6 1 A single chain variable fragment 9031
234 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
235 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
236 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
237 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
238 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
239 6MVL 2 H Antibody Fab fragment heavy chain 9606
240 6MVL 3 L Antibody Fab fragment light chain 9606
241 5OB5 2 H fAb Heavy chain 9606
242 5OB5 3 L fAb Light chain 9606
243 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
244 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
245 5I66 1 A 8B6 antibody, heavy chain 10090
246 5I66 2 B 8B6 antibody, light chain 10090
247 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
248 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
249 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
250 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
251 6BZY 1 H 22D11 Heavy Chain 10090
252 6BZY 2 L 22D11 Light Chain 10090
253 3QQ9 1 C, L 101F LIGHT CHAIN 10090
254 3QQ9 2 D, H 101F HEAVY CHAIN 10090
255 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
256 5TKK 3 L mouse antibody vFP5.01 light chain 10090
257 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
258 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
259 5W6C 1 H UCA Fab heavy chain 9606
260 5W6C 2 L UCA Fab light chain 9606
261 5I1K 1 L FAB LIGHT CHAIN 9606
262 5I1K 2 H FAB HEAVY CHAIN 9606
263 3OZ9 1 L Fab NC-1 kappa light chain 10090
264 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
265 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
266 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
267 5V7U 1 L CBTAU-22.1 Fab light chain 9606
268 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
269 5UEA 1 A, H Fab Heavy Chain 9606
270 5UEA 3 B, L Fab Light Chain 9606
271 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
272 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
273 3G5Y 1 A 175 light chain 10090
274 3G5Y 2 B 175 heavy chain 10090
275 5NMV 1 L Fab light chain 10088
276 5NMV 2 H Fab heavy chain 10088
277 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
278 4N8C 2 L, M Light chain of monoclonal antibody 10090
279 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
280 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
281 4HGW 1 A Antibody Fab fragment, light chain 10090
282 4HGW 2 B Antibody Fab fragment, heavy chain 10090
283 1NLB 1 L antibody 19D9D6 light chain 10090
284 1NLB 2 H antibody 19D9D6 heavy chain 10090
285 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
286 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
287 3VFG 1 L 3F8 Light Chain 10090
288 3VFG 2 H 3F8 Heavy Chain 10090
289 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
290 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
291 3QRG 1 L Fab light chain 9606
292 3QRG 2 H Fab heavy chain Fd fragment 9606
293 5M6A 1 A, B, C, D Bence-Jones light chain 9606
294 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
295 4LLY 2 B, D light chain Clambda 9606
296 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
297 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
298 5EZI 1 H Fab c12 heavy chain 9606
299 5EZI 2 L Fab c12 Light chain 9606
300 4K23 1 H anti-uPAR antibody, heavy chain 10090
301 4K23 2 L anti-uPAR antibody, light chain 10090
302 3NCJ 1 L Fab15 Mut8 light chain 9606
303 3NCJ 2 H Fab15 Mut8 heavy chain 9606
304 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
305 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
306 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
307 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
308 5W05 1 L M59 FAB LIGHT CHAIN 10090
309 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
310 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
311 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
312 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
313 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
314 4M61 1 A, C Fab A52 light chain 10090
315 4M61 2 B, D Fab A52 heavy chain 10090
316 5YE3 1 B 2A7D9 VH CH1 chain 10090
317 5YE3 2 A 2A7D9 L chain 10090
318 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
319 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
320 1UM5 1 L Antibody 21H3 L chain 10090
321 1UM5 2 H Antibody 21H3 H chain 10090
322 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
323 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
324 4NWT 1 L APE1531 Ab Fab light chain 9606
325 4NWT 2 H APE1531 Ab Fab heavy chain 9606
326 3WHX 1 A mAb Fab H fragment 10090
327 3WHX 2 B mAb Fab L fragment 10090
328 3NA9 1 L Fab15 light chain 9606
329 3NA9 2 H Fab15 heavy chain 9606
330 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
331 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
332 6RCO 1 A, C R5.004 heavy chain 9606
333 6RCO 2 B, D R5.004 light chain 9606
334 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
335 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
336 4LRI 1 A, B MSL-109 Light Chain 9606
337 4LRI 2 C, P MSL-109 Heavy Chain 9606
338 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
339 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
340 4JN2 1 A, L anti dabigatran Fab 10090
341 4JN2 2 B, H anti dabigatran Fab 10090
342 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
343 4XBE 2 H 4E10 Fab heavy chain 9606
344 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
345 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
346 6BE2 1 H Fab (F598) Heavy Chain 9606
347 6BE2 2 L Fab (F598) Light Chain 9606
348 4JFZ 1 L Fab light chain 9606
349 4JFZ 2 H Fab heavy chain 9606
350 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
351 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
352 3WIF 1 A mAb Fab H fragment 10090
353 3WIF 2 B mAb Fab L fragment 10090
354 5U6A 1 A Light Chain 9606
355 5U6A 2 B Heavy Chain 9606
356 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
357 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
358 3MBX 1 L X836 LIGHT CHAIN 10090
359 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
360 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
361 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
362 6APC 1 H Epididymis luminal protein 214 9606
363 6APC 2 L IGL@ protein 9606
364 4HHA 1 A Fab KE5 Fab fragment KE5 9606
365 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
366 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
367 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
368 4RGO 2 H 14G8 heavy chain Fab 10090
369 4RGO 3 L 14G8 light chain Fab 10090
370 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
371 5GRY 1 A, G diabody 9606
372 5UEK 2 H Fab 12E Heavy Chain 9606
373 5UEK 3 L Fab 12E Light Chain 9606
374 3NAA 1 L Fab15 Mut5 light chain 9606
375 3NAA 2 H Fab15 Mut5 heavy chain 9606
376 1Q0X 1 L Fab 9B1, light chain 10090
377 1Q0X 2 H Fab 9B1, heavy chain 10090
378 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
379 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
380 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
381 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
382 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
383 5IK3 2 B, D 1E03 Fab fragment light chain 9606
384 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
385 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
386 5XLI 1 a, b FabL 10090
387 5XLI 2 c, d FabH 10090
388 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
389 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
390 6DC4 1 H Fab AM22 Heavy Chain 9606
391 6DC4 2 L Fab AM22 Light Chain 9606
392 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
393 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
394 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
395 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
396 4WUK 1 H CH65 heavy chain 9606
397 4WUK 2 L CH65 light chain 9606
398 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
399 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
400 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
401 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
402 5JOP 1 D, L Fab 14.22 light chain 10090
403 5JOP 2 E, H Fab14.22 heavy chain 10090
404 4HPO 1 H CH58 Fab heavy chain 9606
405 4HPO 2 L CH58 Fab light chain 9606
406 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
407 5UKN 2 L DH522UCA Fab fragment light chain 9544
408 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
409 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
410 5IT2 1 H heavy chain 9606
411 5IT2 2 L light chain 9606
412 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
413 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
414 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
415 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
416 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
417 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
418 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
419 5MO3 3 L Fab of monoclonal antibody, light chain 10090
420 5GZ0 1 A, C FM329 light chain 1383439
421 5GZ0 2 B, D FM329 heavy chain 1383439
422 6DW2 1 A 6078 Fab light chain 9606
423 6DW2 2 B 6078 Fab heavy chain 9606
424 6MG4 1 A, B JTO light chain 9606
425 6BQB 1 L MGG4 Fab light chain 9606
426 6BQB 2 H MGG4 Fab heavy chain 9606
427 4PUB 1 H DX-2930 HEAVY CHAIN 9606
428 4PUB 2 L DX-2930 LIGHT CHAIN 9606
429 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
430 6B14 2 L Light chain of Fab BL3-6S97N 10090
431 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
432 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
433 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
434 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
435 5GS3 1 A, H diabody protein 9606
436 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
437 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
438 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
439 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
440 5VKD 2 H Fab Heavy Chain 9606
441 5VKD 3 L Fab light chain 9606
442 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
443 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
444 5XHG 1 A, C polypeptide(L) 10090
445 5XHG 2 B, D polypeptide(H) 10090
446 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
447 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
448 3UYR 1 H antibody Fab heavy chain 10090
449 3UYR 2 L antibody Fab light chain 10090
450 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
451 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
452 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
453 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
454 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
455 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
456 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
457 3OAZ 2 K, L Fab 2G12, light chain 9606
458 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
459 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
460 1ZAN 1 L Fab AD11 Light Chain 10116
461 1ZAN 2 H Fab AD11 Heavy Chain 10116
462 6CJK 1 A, C Immunoglobulin Fab light chain 9986
463 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
464 4N0Y 1 H IGH526 Heavy Chain 9606
465 4N0Y 2 L IGH526 Light Chain 9606
466 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
467 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
468 6OTC 2 H sFab H3 heavy chain 32630
469 6OTC 3 L sFab H3 light chain 32630
470 5MTH 1 A, H antibody Fab heavy chain 10090
471 5MTH 2 B, L antibody Fab light chain 10090
472 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
473 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
474 1RZF 1 L Fab E51 light chain 9606
475 1RZF 2 H Fab E51 heavy chain 9606
476 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
477 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
478 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
479 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
480 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
481 4KTE 2 L GE148 Light Chain Fab 9544
482 5I8O 1 H HMM5 antibody heavy chain 9606
483 5I8O 2 L HMM5 antibody light chain 9606
484 4OUO 1 A anti Bla g 1 scFv 9031
485 4JG0 1 L Fab light chain 9606
486 4JG0 2 H Fab heavy chain 9606
487 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
488 4YGV 2 B, L aDabi-Fab2a light chain 9606
489 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
490 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
491 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
492 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
493 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
494 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
495 3EO0 1 A, C GC-1008 Fab Light Chain 10090
496 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
497 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
498 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
499 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
500 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
501 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
502 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
503 4FQI 3 H antibody CR9114 heavy chain Fab 9606
504 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
505 6S5A 2 H anti P329G LALA Fab heavy chain 10090
506 6S5A 3 L anti P329G LALA Fab light chain 10090
507 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
508 4JHA 2 L D25 light chain 9606
509 6B9Z 1 A Trastuzumab Fab light chain 10090
510 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
511 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
512 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
513 4PTT 1 A Antibody pn132p2C05, light chain 9606
514 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
515 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
516 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
517 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
518 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
519 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
520 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
521 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
522 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
523 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
524 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
525 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
526 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
527 4DGV 1 H HCV1 Heavy Chain Fab 9606
528 4DGV 2 L HCV1 Light Chain 9606
529 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
530 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
531 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
532 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
533 5TH2 1 A, C cetuximab Fab, light chain 10090
534 5TH2 2 B, D cetuximab Fab, heavy chain 10090
535 5I8K 1 L HHH1 Fab Light chain 9606
536 5I8K 2 H HHH1 Fab Heavy chain 9606
537 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
538 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
539 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
540 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
541 1YNL 1 L Ig gamma light chain 10090
542 1YNL 2 H Ig gamma heavy chain 10090
543 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
544 5EPM 2 B, F Antibody Fab fragment light chain 10090
545 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
546 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
547 3UMT 1 A scFv heavy chain and light chain 10090
548 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
549 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
550 4NUJ 1 A PGT152 light chain 9606
551 4NUJ 2 B PGT152 heavy chain 9606
552 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
553 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
554 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
555 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
556 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
557 3U2S 2 B, L PG9 light chain 9606
558 6PE7 1 H FAB Heavy Chain 9606
559 6PE7 2 L FAB Light chain 9606
560 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
561 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
562 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
563 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
564 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
565 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
566 4NUG 1 L PGT151 light chain 9606
567 4NUG 2 H PGT151 heavy chain 9606
568 3IU4 1 H chP3 Fab heavy chain 10090
569 3IU4 2 L chP3 Fab light chain 10090
570 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
571 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
572 6DC8 1 L IgG light chain 10090
573 6DC8 2 H IgG heavy chain 10090
574 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
575 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
576 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
577 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
578 6IAS 1 H Fab NKp46-1 heavy chain 32630
579 6IAS 2 L Fab NKp46-1 light chain 32630
580 1P7K 1 A, L antibody light chain FAB 10090
581 1P7K 2 B, H antibody heavy chain FAB 10090
582 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
583 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
584 3RVV 2 C 4C1 - light chain 10090
585 3RVV 3 D 4C1 - heavy chain 10090
586 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
587 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
588 3P0Y 2 H Fab DL11 heavy chain 9606
589 3P0Y 3 L Fab DL11 light chain 9606
590 4NPY 1 A, L germline PGT121 light chain Fab 9606
591 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
592 6ANA 2 H LL2 Fab Heavy Chain 10090
593 6ANA 3 L LL2 Fab Light Chain 10090
594 5IBU 1 B, L 6652 Light Chain 9606
595 5IBU 2 G, H 6652 Heavy Chain 9606
596 5VPL 2 C 4C1 - LIGHT CHAIN 10090
597 5VPL 3 D 4C1 - HEAVY CHAIN 10090
598 6AOD 1 A FXIa Antibody FAB Light Chain 9606
599 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
600 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
601 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
602 2YPV 2 H FAB 12C1 10090
603 2YPV 3 L FAB 12C1 10090
604 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
605 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
606 4JY5 1 L PGT122 light chain Fab 9606
607 4JY5 2 H PGT122 heavy chain Fab 9606
608 6ELE 1 A, H fAB heavy chain 9606
609 6ELE 2 B, L fAB light chain 9606
610 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
611 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
612 6B5R 1 H CIS42 Fab Heavy chain 9606
613 6B5R 2 L CIS42 Fab Light chain 9606
614 3NAC 1 L Fab15 Mut7 light chain 9606
615 3NAC 2 H Fab15 Mut7 heavy chain 9606
616 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
617 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
618 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
619 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
620 1Q72 1 L Fab M82G2, Light chain 10090
621 1Q72 2 H Fab M82G2, Heavy chain 10090
622 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
623 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
624 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
625 6MNQ 3 L Ab DH727.2 light chain 9544
626 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
627 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
628 4YHO 1 H aDabi-Fab3 heavy chain 9606
629 4YHO 2 L aDabi-Fab3 light chain 9606
630 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
631 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
632 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
633 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
634 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
635 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
636 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
637 4DGY 1 H HCV1 Heavy Chain Fab 9606
638 4DGY 2 L HCV1 Light Chain 9606
639 5EN2 1 A GD01 heavy chain 10090
640 5EN2 2 B GD01 light chain 10090
641 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
642 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
643 6P4Y 1 H 4A10 Fab heavy chain 10090
644 6P4Y 2 L 4A10 Fab light chain 10090
645 3MXW 2 L 5E1 light chain 9606
646 3MXW 3 H 5E1 heavy chain 9606
647 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
648 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
649 3EO9 1 L Efalizumab Fab fragment, light chain 9606
650 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
651 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
652 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
653 6N35 1 K, L Fab 2G12 light chain 9606
654 6N35 2 H, M Fab 2G12 heavy chain 9606
655 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
656 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
657 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
658 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
659 5WUV 1 L light chain 9606
660 5WUV 2 H heavy chain 9606
661 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
662 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
663 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
664 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
665 4JM4 1 H PGT 135 Heavy Chain Fab 9606
666 4JM4 2 L PGT 135 Light Chain Fab 9606
667 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
668 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
669 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
670 5YE4 2 B, D 1A9D7 L chain 10090
671 6B0G 1 C 1245 Antibody, Light Chain 9606
672 6B0G 2 D 1245 Antibody, Heavy Chain 9606
673 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
674 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
675 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
676 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
677 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
678 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
679 6D0X 1 A 2140 Antibody, heavy chain 9606
680 6D0X 2 B 1210 Antibody, light chain 9606
681 6BE4 1 H Fab (F598) Heavy Chain 9606
682 6BE4 2 L Fab(F598) Light Chain 9606
683 5TPP 1 L DH270.5 Fab heavy chain 9606
684 5TPP 2 H DH270.5 Fab light chain 9606
685 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
686 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
687 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
688 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
689 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
690 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
691 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
692 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
693 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
694 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
695 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
696 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
697 5TL5 1 L M2177 LIGHT CHAIN 10090
698 5TL5 2 H M2177 HEAVY CHAIN 10090
699 2FX7 1 L Fab 4E10 Light Chain 9606
700 2FX7 2 H Fab 4E10 Heavy Chain 9606
701 6O39 1 A Antibody F2.I Fab, Light chain 9606
702 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
703 5Y9K 1 L belimumab light chain 9606
704 5Y9K 2 H belimumab heavy chain 9606
705 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
706 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
707 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
708 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
709 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
710 6GLW 3 D, L Fab 1D11 - Light chain 9844
711 3WFH 1 A mAb Fab H fragment 10090
712 3WFH 2 B mAb Fab L fragment 10090
713 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
714 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
715 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
716 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
717 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
718 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
719 6GKU 2 H Fab 6F5 - Heavy Chain 9844
720 6GKU 3 L Fab 6F5 - Light chain 9844
721 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
722 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
723 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
724 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
725 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
726 5HI4 3 D, L CAT-2000 FAB light chain 9606
727 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
728 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
729 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
730 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
731 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
732 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
733 3RVW 2 C 4C1 - light chain 10090
734 3RVW 3 D 4C1 - heavy chain 10090
735 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
736 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
737 5XKU 2 B HNIgGA6 light chain 9606
738 5XKU 3 C HNIgGA6 heavy chain 9606
739 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
740 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
741 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
742 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
743 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
744 5HI5 3 D, L CAT-2000 light chain 9606
745 5JO5 1 A, C, E, H 10E8 gHV 9606
746 5JO5 2 B, D, F, L 10E8 gLV 9606
747 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
748 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
749 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
750 5CCK 2 L Antibody 3BC315 Fab light chain 9606
751 6RNN 1 C, L Immunoglobulin light chain 10090
752 6GXX 1 H FAB 1D9 heavy chain 10090
753 6GXX 2 L FAB 1D9 light chain 10090
754 5I76 1 A, C FM318_light_chain 1383439
755 5I76 2 B, D FM318_heavy_cahin 1383439
756 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
757 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
758 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
759 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
760 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
761 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
762 5I18 1 L FAB LIGHT CHAIN 9606
763 5I18 2 H FAB HEAVY CHAIN 9606
764 6QB3 2 X scFv55 9606
765 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
766 4JN1 2 L anti-dabigatran Fab1, light chain 10090
767 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
768 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
769 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
770 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
771 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
772 4G5Z 2 L canakinumab antibody fragment light chain 9606
773 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
774 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
775 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
776 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
777 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
778 2OK0 2 L Fab ED10 light chain 10090
779 2OK0 3 H Fab ED10 heavy chain 10090
780 3SOB 1 L antibody light chain 9606
781 3SOB 3 H antibody heavy chain 9606
782 6B5M 1 H CIS43 Fab Heavy chain 9606
783 6B5M 2 L CIS43 Fab Light chain 9606
784 5AWN 1 H Heavy chain of 3BC176 Fab 9606
785 5AWN 2 L Light chain of 3BC176 Fab 9606
786 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
787 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
788 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
789 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
790 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
791 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
792 5DR5 2 L AbD09097 Fab light chain 9606
793 6MG5 1 A, B Light chain JTO 9606
794 2IH3 1 A FAB Heavy Chain 10090
795 2IH3 2 B FAB Light Chain 10090
796 4KQ3 1 L CNTO3186 light chain Fab 9606
797 4KQ3 2 H CNTO3186 heavy chain Fab 9606
798 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
799 6AQ7 3 L POM6 FAB light CHAIN 10090
800 4JFX 1 A, L Fab light chain 9606
801 4JFX 2 B, H Fab heavy chain 9606
802 3SGE 1 I, L Light Chain 10090
803 3SGE 2 H, J Heavy Chain 10090
804 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
805 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
806 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
807 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
808 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
809 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
810 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
811 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
812 5FHB 1 H Antibody 100 Fab heavy chain 9606
813 5FHB 2 L Antibody 100 Fab light chain 9606
814 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
815 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
816 1JGU 1 L Antibody Light Chain 10090
817 1JGU 2 H Antibody Heavy Chain 10090
818 4I77 1 H Lebrikizumab heavy chain Fab 9606
819 4I77 2 L Lebrikizumab light chain Fab 9606
820 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
821 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
822 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
823 4O4Y 2 H 2095-2 heavy chain 9986
824 5OBF 1 H fAb Heavy chain 10090
825 5OBF 2 L fAb Light chain 10090
826 6QNK 1 A, C FAB light chain 10090
827 6QNK 2 B, D FAB heavy chain 10090
828 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
829 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
830 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
831 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
832 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
833 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
834 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
835 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
836 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
837 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
838 5MHE 1 L Fab-fragment 10090
839 5MHE 2 H Fab-fragment 10090
840 5YFI 1 L Light chain of Fab fragment 10090
841 5YFI 2 H Heavy chain of Fab fragment 10090
842 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
843 4GLR 3 I, K anti-ptau light chain light chain 9031
844 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
845 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
846 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
847 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
848 4HJG 1 A Trastuzumab light chain 9606
849 4HJG 2 B Trastuzumab heavy chain 9606
850 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
851 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
852 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
853 5I30 1 L Fab PL-2 light chain 10090
854 5I30 2 H Fab PL-2 heavy chain 10090
855 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
856 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
857 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
858 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
859 6CT7 1 B, L BIIB054 Fab light chain 9606
860 6CT7 2 A, H BIIB054 Fab heavy chain 9606
861 3FN0 1 L Fab Z13e1 light chain 9606
862 3FN0 2 H Fab Z13e1 heavy chain 9606
863 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
864 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
865 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
866 4YHI 2 B, L aDabi-Fab2a light chain 9606
867 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
868 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
869 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
870 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
871 4OSU 1 H SM5-1 Fab Heavy Chain 9606
872 4OSU 2 L SM5-1 Fab Light Chain 9606
873 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
874 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
875 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
876 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
877 1T2Q 1 L Fab NNA7 Heavy Chain 10090
878 1T2Q 2 H Fab NNA7 Light Chain 10090
879 6ELJ 1 A, H fAB heavy chain 9606
880 6ELJ 2 B, L fAB light chain 9606
881 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
882 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
883 4MAU 1 L C2244 light chain SEE REMARK 999 10090
884 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
885 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
886 3LEX 2 B, L 11f10 Antibody Light Chain 10090
887 6B0W 1 L 1710 antibody, light chain 9606
888 6B0W 2 H 1710 antibody, heavy chain 9606
889 6DC7 1 L, M Fab light chain 10090
890 6DC7 2 H, I Fab heavy chain 10090
891 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
892 5VH4 2 B, L Infliximab Fab Light Chain 10090
893 6NOU 1 A scFv derived from ixekizumab 9606
894 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
895 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
896 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
897 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
898 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
899 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
900 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
901 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
902 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
903 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
904 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5 10090
905 1NBY 1 A antibody kappa light chain first chain of Anti-Lysozyme Antibody HyHEL-63 light chain 10090
906 1NBY 2 B immunoglobulin gamma 1 chain second chain of Anti-Lysozyme Antibody HyHEL-63 10090
907 3V6O 2 C, D Monoclonal antibody 9F8 fab fragment Heavy chain Fab fragment of monoclonal antibody H chain 10090
908 3V6O 3 E, F Monoclonal antibody 9F8 fab fragment Light chain Fab fragment of monoclonal antibody L chain 10090
909 3S96 1 A, C 3B5H10 FAB heavy chain 10090
910 3S96 2 B, D 3B5H10 FAB light chain 10090
911 6CBV 1 H Heavy chain, Fab fragment 9606
912 6CBV 2 L Light Chain, Fab fragment 9606
913 4LKX 1 A Fab fragment heavy chain 9606
914 4LKX 2 B Fab fragment light chain 9606
915 1Q9O 1 B, D S45-2 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
916 1Q9O 2 A, C S45-2 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
917 6QB9 1 A, X scFv55